Merola, E; Alonso Gordoa, T; Zhang, P; Al-Toubah, T; Pelle, E; Kolasińska-Ćwikła, A; Zandee, W T; Laskaratos, F M; de Mestier, L; Lamarca, A; Hernando, J; Cwikla, J B; Strosberg, J; de Herder, W W; Caplin, M; Cives, M; van Leeuwaarde, R S
(AlphaMed Press, 2021-04)
Background: Long-acting somatostatin analogs (SSAs) are the primary first-line treatment of well-differentiated advanced gastroenteropancreatic neuroendocrine tumors (NETs), but data about their efficacy in pancreatic NETs ...